Bipolar Disorder Treatment Market expected to reach USD 6,410.25 million by 2030

PRESS RELEASE
Published November 1, 2023

Bipolar Disorder Treatment Market report gives strength to organization and makes better decisions for steering the business on the right track. A strong research methodology used comprises of data models that include market overview and guide, vendor positioning grid, market time line analysis, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. Moreover, only dependable sources such as journals, newspapers, company websites, and annual reports of the companies have been referred to collect the data which can be trusted confidently. It suits the requirements of small, medium as well as large size of businesses.

Bipolar disorder is a chronic mental health condition characterized by extreme mood swings, including manic and depressive episodes. The global bipolar disorder treatment market includes various pharmaceuticals, psychotherapies, and other interventions aimed at managing and alleviating the symptoms of the disorder. The use of digital health technologies, telemedicine, and mobile apps for mental health monitoring and management has expanded treatment options and increased patient engagement.

Data Bridge Market Research analyses that the global bipolar disorder treatment market which was USD 5,200.00 million in 2022, expected to reach USD 6,410.25 million by 2030, and is expected to undergo a CAGR of 2.6% during the forecast period 2023-2030. This indicates the market value. “Bipolar I” dominates the bipolar disorders type segment of the global bipolar disorder treatment market owing to the growing demand for better methods of bone related treatment. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Request a Sample PDF:  https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-bipolar-disorder-treatment-market&Shri

The global bipolar disorder treatment market is the collective pharmaceuticals, therapies, and interventions aimed at managing and alleviating the symptoms and effects of bipolar disorder on a worldwide scale. Bipolar disorder, also known as manic-depressive illness, is a mental health condition characterized by extreme mood swings, including episodes of mania (elevated, high-energy mood) and depression (low, sad, or irritable mood). These mood swings can significantly impact a person’s daily life, relationships, and overall well-being.

Drivers

  • Increasing Prevalence of Bipolar Disorder

The growing awareness and diagnosis of bipolar disorder have contributed to the expansion of the treatment market. Improved recognition of the condition has led to a higher demand for treatments.

  • Advancements in Drug Development

Pharmaceutical companies have been actively investing in research and development to create more effective and targeted drugs for bipolar disorder. New drug formulations with fewer side effects and improved efficacy have emerged, attracting both patients and healthcare professionals.

Opportunity

  • Increasing Healthcare Expenditure

As healthcare spending continues to rise in many countries, there is more financial support available for the diagnosis and treatment of mental health conditions, including bipolar disorder.

Restraint/Challenge

  • Limited Access to Care

Disparities in access to mental healthcare, including shortages of mental health professionals and treatment facilities, can hinder timely and effective treatment for individuals with bipolar disorder, particularly in underserved areas.

Recent Development

  • In September 2022, Otsuka America Pharmaceutical, Inc., (Otsuka) and H.Lundbeck A/S (Lundbeck) announced that the U.S. FDA approved their New Drug Application (NDA) for aripiprazole 2-month, ready-to-use, long-acting injectable, a medication administered for the treatment of bipolar I disorder in adults. This approval helped the company to expand their customer base

Explore the Full Report:  https://www.databridgemarketresearch.com/reports/global-bipolar-disorder-treatment-market?Shri

Some of the major players operating in the global bipolar disorder treatment market are:

  • Johnson & Johnson Services, Inc.(U.S.)
  • AbbVie Inc.(U.S.)
  • Allergan (Ireland)
  • Mallinckrodt (Ireland)
  • Sun Pharmaceutical Industries Ltd.(India)
  • Novartis AG (Switzerland)
  • Endo Pharmaceuticals plc (Ireland)
  • Zydus Cadila (India)
  • Mylan N.V.(U.S.)
  • Mayne Pharma Group Limited (Australia)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Amneal Pharmaceutical Inc.(U.S.)
  • Avet Pharmaceuticals Inc.(U.S.)
  • Lannett (U.S.)
  • Aurobindo Pharma (India)
  • Wockhardt (India)
  • Currax Pharmaceuticals LLC (U.S.)
  • AstraZeneca (U.K.)
  • F. Hoffmann-La Roche Ltd.(Switzerland)
  • Eli Lilly and Company (U.S.)

Bipolar Disorder Treatment Market  Scope

The global bipolar disorder treatment market is segmented on the basis of bipolar disorder type, drug class, mechanism of action, route of administration, distribution channel and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Bipolar Disorders Type

  • Bipolar I
  • Bipolar II

Drug Class

  • Anticonvulsants
  • Antianxiety
  • Mood Stabilizers
  • Antipsychotic
  • Antidepressant
  • Others

Mechanism of Action

  • Selective Serotonin Reuptake Inhibitor
  • Serotonin Norepinephrine Reuptake Inhibitors
  • Tricyclic Antidepressants
  • Monoamine Oxidase Inhibitors
  • Benzodiazepines
  • Beta Blockers

Route of Administration

  • Oral
  • Parenteral
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Investing in this study will provide you with access to valuable information, which includes:

  1. Thorough industry coverage on a global scale, with detailed breakdowns by region.
  2. In-depth analysis of regional markets, encompassing North America, Europe, Asia Pacific, South America, and the Middle East & Africa.
  3. Country-specific market size breakdowns for key countries with significant market shares.
  4. Comprehensive data on market share and revenue/sales from leading industry players.
  5. Examination of market trends, such as emerging technologies, products, and startups, along with PESTEL Analysis, SWOT Analysis, Porter’s Five Forces, and more.
  6. Detailed market size data, including segmentations by application and industry verticals.
  7. Projections and forecasts for the future growth and development of the market.

This Market Intelligence Report Analyses Some of the Most Crucial Concerns:

  1. Anticipated developments in the major segments of the international market in the coming years.
  2. Identification of key players poised to dominate the market in the future.
  3. Assessment of the leading suppliers and producers in this industry.
  4. Examination of growth and expansion strategies implemented by successful industry players.
  5. Insight into sectors expected to experience the most significant demand growth in the near future.
  6. Analysis of the various buyer segments within this market.
  7. Prediction of the regional powerhouse likely to emerge as the dominant player in the international market.
  8. Exploration of the potential impact of a new coronavirus pandemic.
  9. Evaluation of challenges faced by established market players due to the entry of newcomers and strategies to overcome them.

Browse the Comprehensive Research Report Summary with Table of Contents:  https://www.databridgemarketresearch.com/toc/?dbmr=global-bipolar-disorder-treatment-market&Shri

Top DBMR Healthcare Reports:        

Global Bipolar Disorder Treatment Market – Industry Trends and Forecast to 2029

Global Diabetic Macular Edema Treatment Market – Industry Trends and Forecast to 2029

Global 3D Cone Beam Computed Tomography (CBCT) Systems Market – Industry Trends and Forecast to 2029

Global Pregnancy Care Products Market – Industry Trends and Forecast to 2029

Global Hair and Care Market – Industry Trends and Forecast to 2030

Global Vascular Stent Market – Industry Trends and Forecast to 2029

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

Email:- corporatesales@databridgemarketresearch.com

CDN Newswire